Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation

Review Article (Web of Science)

• cited authors: Abulseoud, Osama A.; Alasmari, Fawaz; Hussein, Abdelaziz M.; Sari, Youssef
• publication date: July 5, 2022
• webpage: Web of Science
• published in: FRONTIERS IN NEUROSCIENCE Journal
• category: NEUROSCIENCES Category

keywords

• GLT-1
• ceftriaxone
• glutamate
• neurological disorder
• psychiatric disorder

• volume: 16